Observing pregnancy outcomes in women with multiple sclerosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on women diagnosed with multiple sclerosis (MS) or clinically isolated syndrome (CIS) to gather data on pregnancy outcomes. It aims to assess how pregnancy affects clinical, laboratory, and MRI parameters in these patients. By monitoring these outcomes, the study seeks to provide insights into the relationship between pregnancy and MS. Participants will be followed throughout their pregnancies to collect comprehensive data.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* age \> 18 years
* signed informed consent
* diagnosis of multiple sclerosis or clinically isolated syndrome

Exclusion Criteria:

* clinically relevant comorbidities
* contraindications for MRI, e.g. pacemaker, metal implants, allergy against gadolinium
* alcohol or drug abuse

Where it's running

• Charité Universitätsmedizin Berlin
  Berlin, Germany Recruiting

Study contacts

• Principal investigator: Nadja Siebert, MD — Experimental & Clinical Research Unit, Charité Universitätsmedizin Berlin
• Study coordinator: Nadja Siebert, MD
• Email: nadja.siebert@charite.de

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• QH103 (universal CD19 CAR-γδT) cell injections for relapsed or treatment‑resistant antibody-driven neurological autoimmune diseases

  This Phase 1 test will see if QH103 (universal CD19 CAR-γδT) cell injections are safe and tolerated in adults with relapsed or treatment‑resistant antibody-mediated neurological diseases such as MS, NMOSD, AE, CIDP, or MG.

  Recruiting Phase 1 Tongji Hospital · Wuhan, Hubei · NCT07526493

• Can QSM MRI help tell MS from age-related brain changes in older adults

  This study tests whether an advanced MRI technique called QSM can better differentiate MS-related brain lesions from age-related or small vessel changes in people aged 50–70.

  Recruiting Oslo University Hospital · Oslo, Oslo · NCT07444047

• Escalation versus induction therapy for relapsing MS starting after age 50

  This project will test whether starting with stronger, highly effective treatments or beginning with moderate drugs and escalating later changes the risk of inflammatory relapses for people whose relapsing MS began after age 50.

  Recruiting University Hospital, Strasbourg, France · Strasbourg · NCT07313462

• Impact of a Palliative Care Model on Patient Knowledge and Attitudes

  This study tests if a video about palliative care can help people with Multiple Sclerosis understand their treatment options better than just reading a pamphlet.

  Recruiting at 2 sites Hunter College of City University of New York · New York, New York and 1 other locations · NCT06860932

• Observational study on CNS inflammatory demyelinating diseases in the Chinese population

  This study is looking to understand how certain brain diseases, like Multiple Sclerosis, affect people in China and what factors might influence their progression and treatment.

  Recruiting Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Guangzhou, Guangdong · NCT06541626

• C-CAR168 treatment for autoimmune diseases not responding to standard therapy

  This study is testing a new treatment called C-CAR168 to see if it can help adults with autoimmune diseases that haven't improved with standard therapies.

  Recruiting Phase 1 RenJi Hospital · Shanghai, Shanghai Municipality · NCT06249438

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.